Michael J Hannon
Overview
Explore the profile of Michael J Hannon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
1514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karmakar S, Dettmer S, Hooper C, Hodges N, Hannon M
Angew Chem Int Ed Engl
. 2025 Mar;
:e202503683.
PMID: 40088149
Non-canonical DNA-junction structures are important in human disease and nucleic acid nanoscience and there is a growing interest in how to bind and modulate them. A key next step is...
2.
Shiffman S, Hannon M, McCaffrey S
Health Educ Res
. 2025 Feb;
40(2).
PMID: 39982699
Informing adults who smoke (AWS) that completely switching to electronic nicotine delivery systems (ENDS) reduces their exposure to harmful chemicals could prompt them to switch. However, it would be problematic...
3.
Shiffman S, Hannon M, McCaffrey S, Black R
Patient Educ Couns
. 2024 Oct;
130:108467.
PMID: 39405591
Objective: Numeric rating scales (NRSs) could be inappropriate for assessing constructs such as risk perception if individuals with limited health numeracy (LHN) have difficulty expressing their perceptions on such scales....
4.
Selya A, Hannon M, Shiffman S
Addict Behav
. 2024 Aug;
158:108124.
PMID: 39102771
Background: The Population Assessment of Tobacco and Health (PATH) provides annual prevalence data on youth use of electronic nicotine delivery systems (ENDS). However, trends may be complicated by COVID-related changes...
5.
Melidis L, Hill H, Coltman N, Davies S, Winczura K, Chauhan T, et al.
Angew Chem Weinheim Bergstr Ger
. 2024 Mar;
133(33):18292-18299.
PMID: 38505190
The untranslated regions (UTRs) of viral genomes contain a variety of conserved yet dynamic structures crucial for viral replication, providing drug targets for the development of broad spectrum anti-virals. We...
6.
Shiffman S, Hannon M
Drug Test Anal
. 2023 Jul;
15(10):1281-1296.
PMID: 37489266
Some smokers switch away from smoking using e-cigarettes, but guidelines recommend trying approved medications first. We analyzed switching in adult smokers using JUUL by their recent history of quit attempts...
7.
Selya A, Shiffman S, Hannon M
Addict Behav
. 2023 Jun;
145:107783.
PMID: 37356317
Introduction: Youth use of electronic nicotine delivery systems (ENDS) is a continuing concern, making it important to assess evolving patterns, especially as non-tobacco, non-menthol (NTM) flavors were withdrawn for pod-based...
8.
Craig J, Melidis L, Williams H, Dettmer S, Heidecker A, Altmann P, et al.
J Am Chem Soc
. 2023 Jun;
145(25):13570-13580.
PMID: 37318835
Holliday 4-way junctions are key to important biological DNA processes (insertion, recombination, and repair) and are dynamic structures that adopt either open or closed conformations, the open conformation being the...
9.
Shiffman S, McCaffrey S, Hannon M, Goldenson N, Black R
JMIR Form Res
. 2023 Apr;
7:e44036.
PMID: 37058347
Background: Smokers often experience respiratory symptoms (eg, morning cough), and those who stop smoking, including those who do so by switching completely to electronic nicotine delivery systems (ENDS), may experience...
10.
Melidis L, Styles I, Hannon M
Chem Sci
. 2021 Jun;
12(20):7174-7184.
PMID: 34123344
RNA targeting is an exciting frontier for drug design. Intriguing targets include functional RNA structures in structurally-conserved untranslated regions (UTRs) of many lethal viruses. However, computational docking screens, valuable in...